{"id":"https://openalex.org/W2011608017","doi":"https://doi.org/10.1177/0897190014566308","title":"Dapagliflozin","display_name":"Dapagliflozin","publication_year":2015,"publication_date":"2015-01-21","ids":{"openalex":"https://openalex.org/W2011608017","doi":"https://doi.org/10.1177/0897190014566308","mag":"2011608017","pmid":"https://pubmed.ncbi.nlm.nih.gov/25609661"},"language":"en","primary_location":{"id":"doi:10.1177/0897190014566308","doi":"https://doi.org/10.1177/0897190014566308","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0897190014566308","pdf_url":null,"source":{"id":"https://openalex.org/S182535935","display_name":"Journal of Pharmacy Practice","issn_l":"0897-1900","issn":["0897-1900","1531-1937"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy Practice","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000593144","display_name":"Portia N. Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I48205209","display_name":"Texas Southern University","ror":"https://ror.org/05ch0aw77","country_code":"US","type":"education","lineage":["https://openalex.org/I48205209"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Portia N. Davis","raw_affiliation_strings":["Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA","institution_ids":["https://openalex.org/I48205209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074523090","display_name":"Uche Anadu Ndefo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I48205209","display_name":"Texas Southern University","ror":"https://ror.org/05ch0aw77","country_code":"US","type":"education","lineage":["https://openalex.org/I48205209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uche Anadu Ndefo","raw_affiliation_strings":["Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA","institution_ids":["https://openalex.org/I48205209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104059121","display_name":"Ashley Oliver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I48205209","display_name":"Texas Southern University","ror":"https://ror.org/05ch0aw77","country_code":"US","type":"education","lineage":["https://openalex.org/I48205209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Oliver","raw_affiliation_strings":["Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, USA","institution_ids":["https://openalex.org/I48205209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5000593144"],"corresponding_institution_ids":["https://openalex.org/I48205209"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0439,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.05415002,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"29","issue":"2","first_page":"165","last_page":"171"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antidiabetic-efficacy","display_name":"antidiabetic efficacy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.9729999899864197},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9930694699287415},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9301061034202576},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9285076856613159},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7676870822906494},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5152702331542969},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4972515404224396},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47256985306739807},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42885372042655945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38558995723724365},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3406304121017456},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31678834557533264},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1282547116279602}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0897190014566308","doi":"https://doi.org/10.1177/0897190014566308","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0897190014566308","pdf_url":null,"source":{"id":"https://openalex.org/S182535935","display_name":"Journal of Pharmacy Practice","issn_l":"0897-1900","issn":["0897-1900","1531-1937"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:25609661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25609661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacy practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W175419662","https://openalex.org/W1953840628","https://openalex.org/W1973240292","https://openalex.org/W2001991301","https://openalex.org/W2008443217","https://openalex.org/W2019932241","https://openalex.org/W2025613244","https://openalex.org/W2036127635","https://openalex.org/W2057601938","https://openalex.org/W2060530397","https://openalex.org/W2070351793","https://openalex.org/W2078992128","https://openalex.org/W2080383778","https://openalex.org/W2081510795","https://openalex.org/W2083214694","https://openalex.org/W2114031829","https://openalex.org/W2114276479","https://openalex.org/W2120649968","https://openalex.org/W2121367181","https://openalex.org/W2122077393","https://openalex.org/W2123984464","https://openalex.org/W2167245776","https://openalex.org/W2756318809","https://openalex.org/W4242364069"],"related_works":["https://openalex.org/W2115762589","https://openalex.org/W2335417147","https://openalex.org/W2106426335","https://openalex.org/W2147497075","https://openalex.org/W2010207918","https://openalex.org/W2039104561","https://openalex.org/W2315817175","https://openalex.org/W4250197005","https://openalex.org/W2161841662","https://openalex.org/W2965748936"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"clinical":[3,47,56],"evidence":[4],"for":[5,29,50,75,100,111],"the":[6,30,60,101,112],"efficacy,":[7,61],"safety,":[8,62],"and":[9,63,84],"tolerability":[10,64],"of":[11,32,46,65,103,114],"dapagliflozin":[12,66],"(Farxiga-AstraZeneca),":[13],"a":[14,42],"sodium":[15],"glucose":[16,95],"cotransporter":[17],"2":[18,34,77,105,116],"inhibitor,":[19],"as":[20,67,87,90],"monotherapy":[21,68,88],"or":[22,69,89],"in":[23,70],"combination":[24,71],"with":[25,72],"other":[26,73,94],"hypoglycemic":[27],"agents":[28,97],"treatment":[31,102,113],"type":[33,76,104,115],"diabetes.":[35,78,106,117],"DATA":[36,52],"SOURCES:":[37],"Literature":[38],"was":[39],"identified":[40],"through":[41],"systematic":[43],"MEDLINE":[44],"search":[45],"trial":[48],"results":[49],"dapagliflozin.":[51],"SYNTHESIS:":[53],"Multiple":[54],"controlled":[55],"trials":[57],"have":[58],"established":[59],"therapies":[74],"Dapagliflozin":[79,108],"is":[80,109],"approved":[81],"by":[82],"Food":[83],"Drug":[85],"Administration":[86],"an":[91],"add-on":[92],"to":[93],"lowering":[96],"including":[98],"insulin":[99],"CONCLUSION:":[107],"effective":[110]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}